ECM
ALXN

Everence Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,091
Closed -$1.3M 781
2021
Q2
$1.3M Hold
7,091
0.11% 165
2021
Q1
$1.08M Hold
7,091
0.1% 174
2020
Q4
$1.11M Sell
7,091
-130
-2% -$20.3K 0.11% 156
2020
Q3
$826K Hold
7,221
0.09% 179
2020
Q2
$866K Hold
7,221
0.1% 169
2020
Q1
$648K Hold
7,221
0.09% 185
2019
Q4
$781K Sell
7,221
-1,072
-13% -$116K 0.12% 191
2019
Q3
$812K Hold
8,293
0.13% 164
2019
Q2
$1.09M Buy
8,293
+2,130
+35% +$279K 0.18% 123
2019
Q1
$833K Buy
6,163
+1,868
+43% +$252K 0.15% 149
2018
Q4
$418K Hold
4,295
0.1% 230
2018
Q3
$597K Hold
4,295
0.12% 199
2018
Q2
$533K Hold
4,295
0.11% 213
2018
Q1
$479K Sell
4,295
-2,540
-37% -$283K 0.11% 223
2017
Q4
$817K Buy
6,835
+2,410
+54% +$288K 0.18% 141
2017
Q3
$621K Hold
4,425
0.14% 191
2017
Q2
$538K Hold
4,425
0.13% 210
2017
Q1
$536K Hold
4,425
0.14% 191
2016
Q4
$541K Hold
4,425
0.16% 179
2016
Q3
$542K Hold
4,425
0.16% 179
2016
Q2
$517K Hold
4,425
0.16% 191
2016
Q1
$616K Hold
4,425
0.19% 154
2015
Q4
$844K Hold
4,425
0.27% 107
2015
Q3
$692K Hold
4,425
0.24% 124
2015
Q2
$800K Hold
4,425
0.26% 121
2015
Q1
$798K Hold
4,425
0.27% 119
2014
Q4
$819K Hold
4,425
0.28% 110
2014
Q3
$749K Hold
4,425
0.27% 123
2014
Q2
$691K Hold
4,425
0.26% 131
2014
Q1
$673K Hold
4,425
0.27% 124
2013
Q4
$588K Hold
4,425
0.24% 138
2013
Q3
$514K Hold
4,425
0.22% 137
2013
Q2
$408K Buy
+4,425
New +$408K 0.18% 155